Jetzt bei Plus500 CFDs auf die weltweit gefragtesten Basiswerte wie Aktien, Indizes oder Kryptowährungen entdecken!5 -W-
12.08.2013 12:20:00

Elsevier Launches First Video Journal in Gastrointestinal Endoscopy

MUNICH, August 12, 2013 /PRNewswire/ --

New open access title: Video Journal and Encyclopedia of GI Endoscopy (VJGIEN) now available on ScienceDirect

Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of Video Journal and Encyclopedia of GI Endoscopy (VJGIEN) - an open access video journal providing scientists and clinicians with state-of-the-art visual information of gastrointestinal (GI) pathologies and step-by-step demonstrations and the first of its kind in the field of gastrointestinal endoscopy.

Video Journal and Encyclopedia of GI Endoscopy offers high-quality video demonstrations of endoscopic findings and procedures, presenting the work of gastrointestinal experts in a new and easy to comprehend format. Additional concise articles added to each video detail the procedures and the findings in a bullet point style. All content - videos and articles - are peer-reviewed.

The unique format of the Video Journal and Encyclopedia of GI Endoscopy provides two elements:

(1) An Expert Video Encyclopedia as a clinical reference tool with systematic step-by-step demonstrations of common and rare GI pathologies and up-to-date endoscopic procedures. The video sequences in this section are of high educational impact and allow e.g. endoscopists to recognize a wide array of pathological findings, review existing techniques, and acquire new endoscopic techniques for implementation in their own clinical work.

(2) A Scientific Video Journal for novel findings and techniques, demonstrating cutting edge endoscopic techniques and scientific results as well as clinical cases. In this section of Video Journal and Encyclopedia of GI Endoscopy original research will be published reporting latest results in regard to endoscopic procedures used in the treatment of gastrointestinal diseases.

"GI endoscopy is developing rapidly. Modern endoscopic imaging offers a plethora of detailed visual information and endoscopic procedures are becoming increasingly sophisticated and complex," said Professor Jürgen Pohl from Dr. Horst Schmidt Kliniken GmbH, Wiesbaden, Germany, founder and Editor-in-Chief. "Video Journal and Encyclopedia of GI Endoscopy aims to be the premium and first choice international reference for endoscopic findings and procedures."

"Since endoscopic procedures are based on visual information the idea of this video publication is simple: why read if you can watch," said Dr. Till Meinert, Executive Publisher at Elsevier. "Together with the highly accredited international editorial board we are clearly focusing on our customers' needs."

The Expert Video Encyclopedia will be published in two special issues. Articles regarding Upper GI Tract are available by August 2013; articles regarding Lower GI Tract, by end of August 2013. The first articles of the Scientific Video Journal will be published in fall 2013.

Articles and videos are published open access in Video Journal and Encyclopedia of GI Endoscopy and, therefore, freely available to readers on ScienceDirect.

 

About the Editorial Team

Professor Jürgen Pohl (Dr. Horst Schmidt Kliniken GmbH, Wiesbaden, Germany) founded Video Journal and Encyclopedia of GI Endoscopy as Editor-in-Chief together with associate editor Professor Shou-jiang Tang (University of Mississippi Medical Center, Jackson, MS, USA) and the editors Professor Friedrich Hagenmüller (Asklepios Klinik Altona, Hamburg, Germany), Professor Prateek Sharma (University of Kansas, USA), and Professor Hironori Yamamoto (Jichi Medical University, Tochigi, Japan), in cooperation with the highly accredited international Editorial Board.

About Open Access Publishing at Elsevier

Elsevier has been providing open access publishing options since 2005. Today, researchers can choose to publish open access in over 1,600 established peer-reviewed journals as well as 46 full open access journals and these numbers will continue to grow rapidly. All of Elsevier's open access publications have been peer reviewed, ensuring that the broader community not only reads the latest research but that it is factual, original and of the highest quality and ethical standards. For more information about Elsevier's open access program, visit http://www.elsevier.com/openaccess

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.

Media contact
Dr. Vanessa Quodt
Elsevier GmbH
+49-89-53-83-355
v.quodt@elsevier.com


SOURCE Elsevier

Nachrichten zu Reed Elsevier NV (spons. ADRs)mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Reed Elsevier NV (spons. ADRs)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!